Sonnet BioTherapeutics Holdings, Inc. short interest in 2023
In 2023, Sonnet BioTherapeutics Holdings, Inc.'s disclosed short interest ran from 1.81% of shares outstanding on 15 May 2023 to 3.69% on 29 Dec 2023, a change of +1.88 percentage points. The year's high was 3.69% on 29 Dec 2023 and its low 1.30% on 31 Jul 2023, averaging 2.26% across 8 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 1.52 days on 29 Dec 2023. Full history: Sonnet BioTherapeutics Holdings, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2023 in figures
- Start of year
- 1.81% (15 May 2023)
- End of year
- 3.69% (29 Dec 2023)
- Change
- +1.88 pp
- High
- 3.69% (29 Dec 2023)
- Low
- 1.30% (31 Jul 2023)
- Average
- 2.26%
- Highest days to cover
- 1.52 (29 Dec 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 May 2023 | 1.81% | 1.00 | 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 30 Jun 2023 | 2.66% | 1.00 | |
| 14 Jul 2023 | 2.14% | 1.00 | |
| 31 Jul 2023 | 1.30% | 1.00 | |
| 15 Aug 2023 | 1.48% | 1.00 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 1.92% | 1.00 | |
| 15 Dec 2023 | 3.05% | 1.38 | 10-K filed, results (8-K) |
| 29 Dec 2023 | 3.69% | 1.52 |
See also: Sonnet BioTherapeutics Holdings, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.